Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
NCT ID: NCT04119856
Last Updated: 2021-01-22
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
144 participants
Study Classification
INTERVENTIONAL
Study Start Date
2017-09-25
Study Completion Date
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study examines the effects of the work of an outgoing lung team in the Municipality of Aarhus, Denmark to patients with COPD (Chronic obstructive pulmonary disease) at risk of exacerbation of COPD.
The outgoing lung team is a cross-sectorial team of nurses and doctors from Department of Respiratory Diseases and Allergy at Aarhus University Hospital and nurses from the Acute Team in the Municipality of Aarhus.
The work of the outgoing lung team takes place in the patient's home and involves the following:
* The outgoing lung team teaches the patients, relatives and primary care staff about symptoms, treatments and instructions related to COPD.
* The patients, relatives and primary care staff can contact the outgoing lung team by telephone day and night.
* The outgoing lung team initiates appropriate treatment by telephone or a home visit in consultation with a doctor.
* The patients report symptoms and measurements to the outgoing lung team using telemedicine solutions (AmbuFlex).
* The outgoing lung team initiates acute consultations at Department of Respiratory Diseases and Allergy based on patient reported outcomes, home visit or telephone call.
Half of the participants are affiliated to the outgoing lung team, while the other half are not, and continue their usual practice by contacting the general practitioners in case of exacerbation of COPD.
The main hypothesis of the project is that outgoing lung team has a positive impact on continuity of care across sectors in the Danish healthcare system for patients with COPD. More specifically the hypotheses are:
1. Affiliation to the outgoing lung team reduces admissions, readmissions, length of hospital stay and outpatient consultations.
2. Affiliation to the outgoing lung team reduces anxiety and depression and increases patient involvement, and improves patients' health status and self-efficacy.
3. Affiliation to the outgoing lung team increases patients' level of health literacy.
The outgoing lung team is a cross-sectorial team of nurses and doctors from Department of Respiratory Diseases and Allergy at Aarhus University Hospital and nurses from the Acute Team in the Municipality of Aarhus.
The work of the outgoing lung team takes place in the patient's home and involves the following:
* The outgoing lung team teaches the patients, relatives and primary care staff about symptoms, treatments and instructions related to COPD.
* The patients, relatives and primary care staff can contact the outgoing lung team by telephone day and night.
* The outgoing lung team initiates appropriate treatment by telephone or a home visit in consultation with a doctor.
* The patients report symptoms and measurements to the outgoing lung team using telemedicine solutions (AmbuFlex).
* The outgoing lung team initiates acute consultations at Department of Respiratory Diseases and Allergy based on patient reported outcomes, home visit or telephone call.
Half of the participants are affiliated to the outgoing lung team, while the other half are not, and continue their usual practice by contacting the general practitioners in case of exacerbation of COPD.
The main hypothesis of the project is that outgoing lung team has a positive impact on continuity of care across sectors in the Danish healthcare system for patients with COPD. More specifically the hypotheses are:
1. Affiliation to the outgoing lung team reduces admissions, readmissions, length of hospital stay and outpatient consultations.
2. Affiliation to the outgoing lung team reduces anxiety and depression and increases patient involvement, and improves patients' health status and self-efficacy.
3. Affiliation to the outgoing lung team increases patients' level of health literacy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
NCT00772733
COPD
Chronic Diseases
COMPLETED
Prevalence of Pulmonary Hypertension in COPD Patients
NCT00614900
COPD
Pulmonary Hypertension
COMPLETED
Prognosis and Treatment of COPD in Primary Care-use of Biomarkers
NCT01698151
Chronic Obstructive Pulmonary Disease (COPD)
UNKNOWN
Testing a Prediction Algorithm Into a Running Telehealth System for Patients With COPD
NCT05218525
Chronic Obstructive Pulmonary Disease
COPD Exacerbation
COPD Exacerbation Acute
+1 more
COMPLETED
NA
A Study Into Airways Disease Case Finding and Management
NCT03355677
COPD
Asthma
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background
Worldwide, COPD is a major cause of morbidity and mortality and is currently the fourth leading cause of death and projected to be the third leading cause of death by 2020. In 2010, the estimated number of COPD cases worldwide was 384 million with a prevalence of 11% (95% confidence interval: 8,4%-15,0%).
COPD is characterised by airway obstruction due to inflammation and destruction of lung tissue. The disease causes breathlessness, cough, mucus and frequent respiratory infections and leads to decreased lung function. COPD often affects patients' quality of life negatively as many experience anxiety because of breathlessness. Breathing difficulties reduce patients' level of activity and can lead to social isolation. In Denmark, it is estimated that 320,000 Danes have COPD. In 2018, the number of admissions due to COPD in Denmark was 34,961 with a readmission rate (new hospitalisation within 30 days after the last hospitalisation) of 19% and a 30-day mortality rate of 11%.There were 49,424 outpatient visits due to COPD in Denmark in 2018, and approximately 5,500 annual deaths where COPD is the direct or contributory cause.
It is estimated that the total annual treatment costs for patients with COPD in Denmark amount to approximately DKK 3,345 billion, and most of these costs are related to acute admissions.
Previous research shows that patients with COPD experience not being offered the same quality of treatment as other chronic patients. Furthermore, patients with COPD report that they are not taken seriously by healthcare professionals, which induces insecurity.
As patients with COPD constitute a large group in both the primary and secondary care, we intend to improve the collaboration between the two sectors based on patients´ preferences. The patients emphasized the importance of having the possibility to contact a specialised respiratory nurse 24-7. Patients reported that they preferred education to take place close to home, as transportation to hospital or the community support centre for older people were both mentally and physically straining.
Research showed that home visits by a respiratory nurse from the hospital reduce admissions and readmissions. Furthermore, research showed that home visits by the nurses in primary care also decrease admissions and readmissions. Some of the interventions were treatment at home and some comprised education regarding management of acute exacerbations and observations of symptoms, inhalation, smoking cessation, nutrition etc.
The interventions consisted of collaboration between primary care nurses and the general practitioners (GPs), and in other interventions primary care nurses were supervised by the specialist respiratory nurses at the hospital often by phone or at joint visits in the patients' home.
Home visits after discharge paid by a respiratory nurse and interdisciplinary cooperation showed that patients with COPD felt safe and comforted and were motivated to make changes to achieve better health.
However, other studies showed that education improved patients' knowledge but it did not prevent readmissions.
So far, no studies have been performed investigating cross-sectorial collaboration with a lung team and preventive intervention in patients at risk of hospitalisation due to exacerbation of COPD.
Department of Respiratory Diseases and Allergy at Aarhus University Hospital, Denmark and the Acute Team in the Municipality of Aarhus, Denmark started a pilot project from September 2015 until October 2016. The project concerned establishment of an outgoing lung team comprised by a team of nurses from both the primary and secondary sector. The aim was to increase knowledge and competences among patients, relatives and staff in relation to care and treatment, to reduce the rate of hospitalisation and readmission and to evaluate the impact of the outgoing lung team on participants' health status. The pilot project had several limitations 1) It was only possible to evaluate the effect of the outgoing lung team during six months. We were thus unable to evaluate variety over the year which may have impacted on the number of hospitalisations, readmissions and episodes of exacerbation. 2) The pilot project had no control group. We thus wanted to qualify the project by using a randomised controlled trial design.
We also wanted to examine the impact of the outgoing lung team on the level of patient involvement, anxiety, depression and health literacy. Health literacy is linked to literacy and entails people's knowledge, motivation and competences to access, understand, appraise and apply health information in order to make judgements and take decisions in everyday life concerning health care, disease prevention and health promotion to maintain or improve quality of life during the life course. Studies show that patients with COPD have lower levels of health literacy compared with people with no chronic diseases. Increasing the level of health literacy in this population would thus be relevant.
Furthermore, we wished to examine the effect of the outgoing lung team on patients' health status, their experiences of being affiliated to the outgoing lung team as well as their self-efficacy.
Objective
The aim is to examine the effects of the work of an outgoing lung team in the Municipality of Aarhus to patients with COPD at risk of exacerbation of COPD.
Hypothesis
The main hypothesis is that outgoing lung team has a positive impact on continuity of care across sectors in the Danish healthcare system for patients with COPD. To examine this we have three subhypotheses.
1. Affiliation to the outgoing lung team reduces admissions, readmissions, length of hospital stay and outpatient consultations.
2. Affiliation to the outgoing lung team reduces anxiety and depression and increases patient involvement, and improves patients' health status and self-efficacy.
3. Affiliation to the outgoing lung team increases patients' level of health literacy.
Materials and method
Setting and location
The outgoing lung team is a cross-sectorial team of nurses and doctors from Department of Respiratory Diseases and Allergy at Aarhus University Hospital in Denmark and nurses from the Acute Team in the Municipality of Aarhus in Denmark. The outgoing lung team intends to preserve, detect, diagnose and treat patients with an exacerbation of COPD. The outgoing lung team is physically located at the office of the Acute Team; in this office knowledge sharing and upgrading of skills take place.
The work of the outgoing lung team takes place in the patient's home and involves the following:
* The outgoing lung team teaches the patients, relatives and primary care staff about symptoms, treatments and instructions related to COPD.
* The patients, relatives and primary care staff can contact the outgoing lung team by telephone day and night.
* The patients report symptoms and measurements to the outgoing lung team using telemedicine solutions, also known as patient reported outcomes.
* The outgoing lung team initiates appropriate treatment by telephone or a home visit. The outgoing lung team always consults a doctor from the Department of Respiratory Diseases and Allergy before initiating treatment.
* The outgoing lung team initiates acute consultations at Department of Respiratory Diseases and Allergy based on patient reported outcomes, home visit or telephone call.
Doctors at Department of Respiratory Diseases and Allergy are responsible for the medical treatment as long as the patient participates in the project. The GPs in the Municipality of Aarhus have agreed to this. The GPs can refer patients to the project and some of them participate in a project advisory board.
Study design
The project is designed as a mixed-method study based on a randomised controlled trial with an intervention group connected to the outgoing lung team and a control group attending the standard pathway programme at Department of Respiratory Diseases and Allergy at Aarhus University Hospital, Denmark.
Sample size
Based on a retrospective sample of admissions related to COPD in the period from February to August 2014-2016, an expected decrease in length of hospital stay can be calculated as the outgoing lung team was introduced in 2016. Mean number of admission days in the retrospective sample followed a normal distribution after logarithmic transformation, as assessed by histograms. Number of admission days (geometric mean) was 5.69 (95% CI: 2.78-11.6) in 2014-2015, and 4.50 (2.62-7.76) in 2016. Based on these numbers, the power calculation resulted in inclusion of 64 patients in the intervention and control group, respectively to be able to demonstrate a significant difference with a power of 80% and at a significance level of 5%.
In the pilot project the withdrawal was 23%. With an estimated withdrawal at 23% we will need 83 patients in each group.
Missing data
After one year, we contact all participants and arrange a plan for answering the questionnaires. The missing data, will be registered in Stata and mentioned in the study.
Analysis
Data will be statistically analysed both descriptive and analytically. Correlations and significant factors as lung function, gender, age etc. will be examined and significant differences between the two groups (intervention group and control group) in the studies which may have an impact on results.
To identify predictors of the impact on the dependent variable we will use bivariate x 2 test and calculation of odds ratios, multiple logistic regression and logarithmic data. The statistical analysis will be performed in Stata 16.
Qualitative data from the interviews in will be transcribed and analysed based on meaning condensation analysis.
Ethics
Ethical approval will be obtained from Central Denmark Region Committees on Health Research Ethics and approval of data archives and storage will be obtained from the Danish Data Protection Agency in Central Denmark Region in RedCap. All collected personal data will be anonymised, processed, analysed and stored in accordance with the Danish Data Protection Agency. All participants will receive oral and written information. Patients who agree to participate will provide written informed consent.
Worldwide, COPD is a major cause of morbidity and mortality and is currently the fourth leading cause of death and projected to be the third leading cause of death by 2020. In 2010, the estimated number of COPD cases worldwide was 384 million with a prevalence of 11% (95% confidence interval: 8,4%-15,0%).
COPD is characterised by airway obstruction due to inflammation and destruction of lung tissue. The disease causes breathlessness, cough, mucus and frequent respiratory infections and leads to decreased lung function. COPD often affects patients' quality of life negatively as many experience anxiety because of breathlessness. Breathing difficulties reduce patients' level of activity and can lead to social isolation. In Denmark, it is estimated that 320,000 Danes have COPD. In 2018, the number of admissions due to COPD in Denmark was 34,961 with a readmission rate (new hospitalisation within 30 days after the last hospitalisation) of 19% and a 30-day mortality rate of 11%.There were 49,424 outpatient visits due to COPD in Denmark in 2018, and approximately 5,500 annual deaths where COPD is the direct or contributory cause.
It is estimated that the total annual treatment costs for patients with COPD in Denmark amount to approximately DKK 3,345 billion, and most of these costs are related to acute admissions.
Previous research shows that patients with COPD experience not being offered the same quality of treatment as other chronic patients. Furthermore, patients with COPD report that they are not taken seriously by healthcare professionals, which induces insecurity.
As patients with COPD constitute a large group in both the primary and secondary care, we intend to improve the collaboration between the two sectors based on patients´ preferences. The patients emphasized the importance of having the possibility to contact a specialised respiratory nurse 24-7. Patients reported that they preferred education to take place close to home, as transportation to hospital or the community support centre for older people were both mentally and physically straining.
Research showed that home visits by a respiratory nurse from the hospital reduce admissions and readmissions. Furthermore, research showed that home visits by the nurses in primary care also decrease admissions and readmissions. Some of the interventions were treatment at home and some comprised education regarding management of acute exacerbations and observations of symptoms, inhalation, smoking cessation, nutrition etc.
The interventions consisted of collaboration between primary care nurses and the general practitioners (GPs), and in other interventions primary care nurses were supervised by the specialist respiratory nurses at the hospital often by phone or at joint visits in the patients' home.
Home visits after discharge paid by a respiratory nurse and interdisciplinary cooperation showed that patients with COPD felt safe and comforted and were motivated to make changes to achieve better health.
However, other studies showed that education improved patients' knowledge but it did not prevent readmissions.
So far, no studies have been performed investigating cross-sectorial collaboration with a lung team and preventive intervention in patients at risk of hospitalisation due to exacerbation of COPD.
Department of Respiratory Diseases and Allergy at Aarhus University Hospital, Denmark and the Acute Team in the Municipality of Aarhus, Denmark started a pilot project from September 2015 until October 2016. The project concerned establishment of an outgoing lung team comprised by a team of nurses from both the primary and secondary sector. The aim was to increase knowledge and competences among patients, relatives and staff in relation to care and treatment, to reduce the rate of hospitalisation and readmission and to evaluate the impact of the outgoing lung team on participants' health status. The pilot project had several limitations 1) It was only possible to evaluate the effect of the outgoing lung team during six months. We were thus unable to evaluate variety over the year which may have impacted on the number of hospitalisations, readmissions and episodes of exacerbation. 2) The pilot project had no control group. We thus wanted to qualify the project by using a randomised controlled trial design.
We also wanted to examine the impact of the outgoing lung team on the level of patient involvement, anxiety, depression and health literacy. Health literacy is linked to literacy and entails people's knowledge, motivation and competences to access, understand, appraise and apply health information in order to make judgements and take decisions in everyday life concerning health care, disease prevention and health promotion to maintain or improve quality of life during the life course. Studies show that patients with COPD have lower levels of health literacy compared with people with no chronic diseases. Increasing the level of health literacy in this population would thus be relevant.
Furthermore, we wished to examine the effect of the outgoing lung team on patients' health status, their experiences of being affiliated to the outgoing lung team as well as their self-efficacy.
Objective
The aim is to examine the effects of the work of an outgoing lung team in the Municipality of Aarhus to patients with COPD at risk of exacerbation of COPD.
Hypothesis
The main hypothesis is that outgoing lung team has a positive impact on continuity of care across sectors in the Danish healthcare system for patients with COPD. To examine this we have three subhypotheses.
1. Affiliation to the outgoing lung team reduces admissions, readmissions, length of hospital stay and outpatient consultations.
2. Affiliation to the outgoing lung team reduces anxiety and depression and increases patient involvement, and improves patients' health status and self-efficacy.
3. Affiliation to the outgoing lung team increases patients' level of health literacy.
Materials and method
Setting and location
The outgoing lung team is a cross-sectorial team of nurses and doctors from Department of Respiratory Diseases and Allergy at Aarhus University Hospital in Denmark and nurses from the Acute Team in the Municipality of Aarhus in Denmark. The outgoing lung team intends to preserve, detect, diagnose and treat patients with an exacerbation of COPD. The outgoing lung team is physically located at the office of the Acute Team; in this office knowledge sharing and upgrading of skills take place.
The work of the outgoing lung team takes place in the patient's home and involves the following:
* The outgoing lung team teaches the patients, relatives and primary care staff about symptoms, treatments and instructions related to COPD.
* The patients, relatives and primary care staff can contact the outgoing lung team by telephone day and night.
* The patients report symptoms and measurements to the outgoing lung team using telemedicine solutions, also known as patient reported outcomes.
* The outgoing lung team initiates appropriate treatment by telephone or a home visit. The outgoing lung team always consults a doctor from the Department of Respiratory Diseases and Allergy before initiating treatment.
* The outgoing lung team initiates acute consultations at Department of Respiratory Diseases and Allergy based on patient reported outcomes, home visit or telephone call.
Doctors at Department of Respiratory Diseases and Allergy are responsible for the medical treatment as long as the patient participates in the project. The GPs in the Municipality of Aarhus have agreed to this. The GPs can refer patients to the project and some of them participate in a project advisory board.
Study design
The project is designed as a mixed-method study based on a randomised controlled trial with an intervention group connected to the outgoing lung team and a control group attending the standard pathway programme at Department of Respiratory Diseases and Allergy at Aarhus University Hospital, Denmark.
Sample size
Based on a retrospective sample of admissions related to COPD in the period from February to August 2014-2016, an expected decrease in length of hospital stay can be calculated as the outgoing lung team was introduced in 2016. Mean number of admission days in the retrospective sample followed a normal distribution after logarithmic transformation, as assessed by histograms. Number of admission days (geometric mean) was 5.69 (95% CI: 2.78-11.6) in 2014-2015, and 4.50 (2.62-7.76) in 2016. Based on these numbers, the power calculation resulted in inclusion of 64 patients in the intervention and control group, respectively to be able to demonstrate a significant difference with a power of 80% and at a significance level of 5%.
In the pilot project the withdrawal was 23%. With an estimated withdrawal at 23% we will need 83 patients in each group.
Missing data
After one year, we contact all participants and arrange a plan for answering the questionnaires. The missing data, will be registered in Stata and mentioned in the study.
Analysis
Data will be statistically analysed both descriptive and analytically. Correlations and significant factors as lung function, gender, age etc. will be examined and significant differences between the two groups (intervention group and control group) in the studies which may have an impact on results.
To identify predictors of the impact on the dependent variable we will use bivariate x 2 test and calculation of odds ratios, multiple logistic regression and logarithmic data. The statistical analysis will be performed in Stata 16.
Qualitative data from the interviews in will be transcribed and analysed based on meaning condensation analysis.
Ethics
Ethical approval will be obtained from Central Denmark Region Committees on Health Research Ethics and approval of data archives and storage will be obtained from the Danish Data Protection Agency in Central Denmark Region in RedCap. All collected personal data will be anonymised, processed, analysed and stored in accordance with the Danish Data Protection Agency. All participants will receive oral and written information. Patients who agree to participate will provide written informed consent.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
COPD
COPD Exacerbation
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
SUPPORTIVE_CARE
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Affiliation with outgoing lung team
* Instructions and teaching by the outgoing lung team.
* Needs-based consultation at Dept. of Respiratory Diseases and Allergy.
* Contact to the outgoing lung team in case of exacerbation of COPD.
Group Type
OTHER
Affiliation with the outgoing lung team
Intervention Type
OTHER
The work of the outgoing lung team takes place in the patient's home and involves the following:
* The outgoing lung team teaches the patients, relatives and primary care staff about symptoms, treatments and instructions related to COPD.
* The patients, relatives and primary care staff can contact the outgoing lung team by telephone day and night.
* The patients report symptoms and measurements to the outgoing lung team using telemedicine as patient reported outcomes.
* The outgoing lung team initiates appropriate treatment by telephone or a home visit. The outgoing lung team always consults a doctor from the Department of Respiratory Diseases and Allergy before initiating treatment.
* The outgoing lung team initiates acute consultations at Department of Respiratory Diseases and Allergy based on patient reported outcomes, home visit or telephone call.
Control group
The usual practice
* Scheduled consultations at Dept. of Respiratory Diseases and Allergy.
* Contact to GP/doctor on call in case of exacerbation of COPD.
Group Type
NO_INTERVENTION
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Affiliation with the outgoing lung team
The work of the outgoing lung team takes place in the patient's home and involves the following:
* The outgoing lung team teaches the patients, relatives and primary care staff about symptoms, treatments and instructions related to COPD.
* The patients, relatives and primary care staff can contact the outgoing lung team by telephone day and night.
* The patients report symptoms and measurements to the outgoing lung team using telemedicine as patient reported outcomes.
* The outgoing lung team initiates appropriate treatment by telephone or a home visit. The outgoing lung team always consults a doctor from the Department of Respiratory Diseases and Allergy before initiating treatment.
* The outgoing lung team initiates acute consultations at Department of Respiratory Diseases and Allergy based on patient reported outcomes, home visit or telephone call.
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Citizens of the Municipality of Aarhus
2. FEV1 \<50% predicted and at least one hospitalisation due to COPD and/or two tablet-treated episodes of exacerbation (prednisolone and /or antibiotics) within the last year
3. Special needs due to anxiety, dyspnea etc. that cause frequent hospitalisations
2. FEV1 \<50% predicted and at least one hospitalisation due to COPD and/or two tablet-treated episodes of exacerbation (prednisolone and /or antibiotics) within the last year
3. Special needs due to anxiety, dyspnea etc. that cause frequent hospitalisations
Exclusion Criteria
1. Participation in the pilot project
2. Inability to speak, read and understand Danish
3. Severe cognitive disability and thus inability to understand and fill in questionnaires (e.g. dementia)
4. No wish to participate in the project
2. Inability to speak, read and understand Danish
3. Severe cognitive disability and thus inability to understand and fill in questionnaires (e.g. dementia)
4. No wish to participate in the project
Minimum Eligible Age
18 Years
Maximum Eligible Age
100 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birgit R Iversen, Ph.d.-stud.
Role: STUDY_DIRECTOR
Department of Respiratory Diseases and Allergy, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Respiratory Diseases and Allergy
Aarhus N, , Denmark
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Denmark
References
Explore related publications, articles, or registry entries linked to this study.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD - 2019. 2019; Available at: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 15.04, 2019.
Reference Type
BACKGROUND
Sundhedsstyrelsen. Anbefalinger for tværsektorielle forløb for mennesker med KOL. 2017; Available at: https://www.sst.dk/da/udgivelser/2017/~/media/8365DCEC9BB240A0BD6387A81CBDBB49.ashx. Accessed 04.07, 2017.
Reference Type
BACKGROUND
Dansk Register for Kronisk Obstruktiv Lungesygdom. Appendiks til National årsrapport 2018. 2019; Available at: https://www.sundhed.dk/content/cms/90/4690_appendix_drkol-aarsrapport-2018_05052019_offentlig.pdf. Accessed 12.08, 2019.
Reference Type
BACKGROUND
Dansk Register for Kronisk Obstruktiv Lungesygdom. National årsrapport 2018. 2019; Available at: https://www.sundhed.dk/content/cms/90/4690_drkol-aarsrapport-2018_offentlig.pdf. Accessed 12.08, 2019.
Reference Type
BACKGROUND
Witzel S, Nielsen PB, Jensen M. Patienternes perspektiv på kronisk sygdom - Oplevelser på tværs af sundhedsvæsenet i Region Midtjylland. CFK - Folkesundhed og Kvalitetsudvikling. 2012; Available at: http://www.defactum.dk/publikationer/ShowPublication?id=421&pageId=309986. Accessed 05.07, 2016.
Reference Type
BACKGROUND
Martin HM, Borst L. Sammenhæng i tværsektorielle KOL - forløb. En undersøgelse af patient er og pårørendes oplevelser. KORA - Det Nationale Institut for Kommuners og Regioners Analyse og Forskning. 2013; Available at: https://www.vive.dk/media/pure/9106/2043881. Accessed 05.07, 2019.
Reference Type
BACKGROUND
Rasmussen L, Ølsgaard G. Forslag til kvalitetsforbedringer fra patienter og fagpersoner i indsatsen for kronisk syge - en opfølgning på rapporten "Patientens perspektiv på kronisk sygdom". CFK - Folkesundhed og Kvalitetsudvikling. 2014; Available at: http://www.defactum.dk/publikationer/ShowPublication?id=435&pageId=309986. Accessed 05.07, 2016.
Reference Type
BACKGROUND
Haggerty MC, Stockdale-Woolley R, Nair S. Respi-Care. An innovative home care program for the patient with chronic obstructive pulmonary disease. Chest. 1991 Sep;100(3):607-12. doi: 10.1378/chest.100.3.607.
Reference Type
BACKGROUND
Pearson S, Inglis SC, McLennan SN, Brennan L, Russell M, Wilkinson D, Thompson DR, Stewart S. Prolonged effects of a home-based intervention in patients with chronic illness. Arch Intern Med. 2006 Mar 27;166(6):645-50. doi: 10.1001/archinte.166.6.645.
Reference Type
BACKGROUND
Transition reduced readmission rate for COPD patients. Hosp Case Manag. 2010 May;18(5):71-3. No abstract available.
Reference Type
BACKGROUND
Ward S, Barnes H, Ward R. Evaluating a respiratory intermediate care team. Nurs Stand. 2005 Oct 12-18;20(5):46-50. doi: 10.7748/ns2005.10.20.5.46.c3975.
Reference Type
BACKGROUND
Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J. 2004 Nov;34(11):608-14. doi: 10.1111/j.1445-5994.2004.00672.x.
Reference Type
BACKGROUND
Matsumura T, Takarada K, Oki Y, Fujimoto Y, Kaneko H, Ohira M, Ishikawa A. Long-term Effect of Home Nursing Intervention on Cost and Healthcare Utilization for Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study. Rehabil Nurs. 2015 Nov-Dec;40(6):384-9. doi: 10.1002/rnj.189. Epub 2014 Nov 25.
Reference Type
BACKGROUND
Spiliopoulos N, Donoghue J, Clark E, Dunford M. Outcomes from a Respiratory Coordinated Care Program (RCCP) providing community-based interventions for COPD patients from 1998 to 2006. Contemp Nurse. 2008 Dec;31(1):2-8. doi: 10.5172/conu.673.31.1.2.
Reference Type
BACKGROUND
Cox K, Macleod SC, Sim CJ, Jones AW, Trueman J. Avoiding hospital admission in COPD: impact of a specialist nursing team. Br J Nurs. 2017 Feb 9;26(3):152-158. doi: 10.12968/bjon.2017.26.3.152.
Reference Type
BACKGROUND
Titova E, Steinshamn S, Indredavik B, Henriksen AH. Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study. Respir Res. 2015 Feb 3;16(1):8. doi: 10.1186/s12931-015-0170-1.
Reference Type
BACKGROUND
Lee G, Pickstone N, Facultad J, Titchener K. The future of community nursing: Hospital in the Home. Br J Community Nurs. 2017 Apr 2;22(4):174-180. doi: 10.12968/bjcn.2017.22.4.174.
Reference Type
BACKGROUND
Davison AG, Monaghan M, Brown D, Eraut CD, O'Brien A, Paul K, Townsend J, Elston C, Ward L, Steeples S, Cubitt L. Hospital at home for chronic obstructive pulmonary disease: an integrated hospital and community based generic intermediate care service for prevention and early discharge. Chron Respir Dis. 2006;3(4):181-5. doi: 10.1177/1479972306070074.
Reference Type
BACKGROUND
Hermiz O, Comino E, Marks G, Daffurn K, Wilson S, Harris M. Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ. 2002 Oct 26;325(7370):938. doi: 10.1136/bmj.325.7370.938.
Reference Type
BACKGROUND
Zwar NA, Hermiz O, Comino E, Middleton S, Vagholkar S, Xuan W, Wilson SF, Marks GB. Care of patients with a diagnosis of chronic obstructive pulmonary disease: a cluster randomised controlled trial. Med J Aust. 2012 Oct 1;197(7):394-8. doi: 10.5694/mja12.10813.
Reference Type
BACKGROUND
Leine M, Wahl AK, Borge CR, Hustavenes M, Bondevik H. Feeling safe and motivated to achieve better health: Experiences with a partnership-based nursing practice programme for in-home patients with chronic obstructive pulmonary disease. J Clin Nurs. 2017 Sep;26(17-18):2755-2764. doi: 10.1111/jocn.13794. Epub 2017 May 17.
Reference Type
BACKGROUND
World Health Organization Europe. Health Literacy - The solid facts. 2013; Available at: http://www.euro.who.int/__data/assets/pdf_file/0008/190655/e96854.pdf?ua=1. Accessed 01.03, 2017.
Reference Type
BACKGROUND
Friis K, Jensen ML, Lasgaard M, Maindal HT. Sundhedskompetence blandt personer med kronisk sygdom. Region Midtjylland CFK - Folkesundhed og Kvalitetsudvikling. 2015; Available at: https://www.rm.dk/siteassets/om-os/aktuelt/nyheder/sundhedskompetence_kronisk_sygdom_2015_temaanalyse.pdf. Accessed 13.07, 2016.
Reference Type
BACKGROUND
Kvale S, Brinkmann S. Interview : det kvalitative forskningsinterview som håndværk. 3rd ed. København: Hans Reitzel; 2015.
Reference Type
BACKGROUND
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
Reference Type
BACKGROUND
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Outgoing Lung Team
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
NCT01219946
COMPLETED
Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics
NCT00268866
COMPLETED
Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement
NCT02346292
COMPLETED
Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients
NCT06348966
NOT_YET_RECRUITING
Screening for COPD in Primary Care: a Synergistic Approach - Dentists - Pharmacists -Physiotherapists - Nurses - Physicians
NCT03104348
TERMINATED
NA
Study for the Validation of the Circuit of Examinations and Analyzes for Better Classification of Airway Diseases
NCT05826522
UNKNOWN
Change in Airway Peripheral Tone in COPD
NCT04166812
UNKNOWN
COPD Case Finding In Nottingham and District: C-FIND COPD A Pilot Study
NCT06008145
ACTIVE_NOT_RECRUITING
Danish Lung Cancer Screening Trial (DLCST)
NCT00496977
UNKNOWN
NA
COPD in the Time of COVID-19
NCT04407598
UNKNOWN
Prevalence, Associated Factors Points and Implementation of Care Procedures of Chronic Obstructive Pulmonary Disease Exacerbation in Healthcare Institution
NCT05682404
COMPLETED
COPD Readmissions Prediction- ReCOPD Project
NCT03227211
COMPLETED
Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
NCT01318174
COMPLETED
Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!
NCT01314807
UNKNOWN
This is a Multicenter, Prospective and Retrospective and Descriptive Epidemiology Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Korea
NCT01419379
COMPLETED
Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD
NCT05437198
RECRUITING
Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma
NCT05525169
UNKNOWN
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267
COMPLETED
Pulmonary Diffusing Capacity During Acute Exercise in Patients With COPD
NCT05583396
UNKNOWN
NA
Study of Hospitalised Patients With Acute Respiratory Conditions
NCT05095090
UNKNOWN
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD
NCT07045948
RECRUITING
NA
Pre-flight Evaluation of Adult Patients With Cystic Fibrosis
NCT01569880
COMPLETED
A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD
NCT07344285
NOT_YET_RECRUITING
NA
Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT03709498
COMPLETED
Effectiveness and Implementation of the Assessment of Burden of Chronic Conditions (ABCC)-Tool
NCT04127383
COMPLETED
NA